_id

690db2efccc777a4e85d0ca9

Ticker

ATXS

Name

Astria Therapeutics Inc

Exchange

NASDAQ

Address

22 Boston Wharf Road, Boston, MA, United States, 02210

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.astriatx.com

Description

Astria Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is navenibart, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in clinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.

Last Close

12.97

Volume

1219622

Current Price

12.91

Change

-0.46260601387818423

Last Updated

2025-11-28T12:32:31.438Z

Image

data:image/webp;base64,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

Ipo Date

2015-06-25T00:00:00.000Z

Market Cap

719268992

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8958

Sentiment Sources

5

Rating

4.7778

Target Price

24.6

Strong Buy

7

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

706000

Cost Of Revenue

-

Gross Profit

706000

Operating Expenses

34810000

Operating Income

-34104000

Interest Expense

-

Pretax Income

-31643000

Net Income

-31643000

Eps

-0.5455190035009208

Dividends Per Share

-

Shares Outstanding

57084838

Income Tax Expense

-

EBITDA

-31643000

Operating Margin

-4830.594900849858

Total Other Income Expense Net

2461000

Cash

96280000

Short Term Investments

131441000

Receivables

17243000

Inventories

-

Total Current Assets

253546000

Property Plant Equipment

4254000

Total Assets

271866000

Payables

1137000

Short Term Debt

1404000

Long Term Debt

-

Total Liabilities

38613000

Equity

233253000

Depreciation

-764000

Change In Working Capital

-4565000

Cash From Operations

-32295000

Capital Expenditures

32295000

Cash From Investing

52253000

Cash From Financing

3000

Net Change In Cash

19961000

PE

-

PB

3.225377151162043

ROE

-13.56595627923328

ROA

-11.639189895021811

FCF

-64590000

Fcf Percent

-91.48725212464589

Piotroski FScore

0

Health Score

29

Deep Value Investing Score

4

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

706000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

706000

Quarters > 0 > income Statement > operating Expenses

34810000

Quarters > 0 > income Statement > operating Income

-34104000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-31643000

Quarters > 0 > income Statement > net Income

-31643000

Quarters > 0 > income Statement > eps

-0.5455190035009208

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

58005312

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-31643000

Quarters > 0 > income Statement > operating Margin

-4830.594900849858

Quarters > 0 > income Statement > total Other Income Expense Net

2461000

Quarters > 0 > balance Sheet > cash

96280000

Quarters > 0 > balance Sheet > short Term Investments

131441000

Quarters > 0 > balance Sheet > receivables

17243000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

253546000

Quarters > 0 > balance Sheet > property Plant Equipment

4254000

Quarters > 0 > balance Sheet > total Assets

271866000

Quarters > 0 > balance Sheet > payables

1137000

Quarters > 0 > balance Sheet > short Term Debt

1404000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

38613000

Quarters > 0 > balance Sheet > equity

233253000

Quarters > 0 > cash Flow > net Income

-31643000

Quarters > 0 > cash Flow > depreciation

-764000

Quarters > 0 > cash Flow > change In Working Capital

-4565000

Quarters > 0 > cash Flow > cash From Operations

-32295000

Quarters > 0 > cash Flow > capital Expenditures

32295000

Quarters > 0 > cash Flow > cash From Investing

52253000

Quarters > 0 > cash Flow > cash From Financing

3000

Quarters > 0 > cash Flow > net Change In Cash

19961000

Quarters > 0 > ratios > PE

-0.5455190035009208

Quarters > 0 > ratios > PB

3.225377151162043

Quarters > 0 > ratios > ROE

-13.56595627923328

Quarters > 0 > ratios > ROA

-11.639189895021811

Quarters > 0 > ratios > FCF

-64590000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-91.48725212464589

Quarters > 0 > health Score

29

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

35820000

Quarters > 1 > income Statement > operating Income

-35820000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-33052000

Quarters > 1 > income Statement > net Income

-33052000

Quarters > 1 > income Statement > eps

-0.5698098822397507

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

58005312

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-35820000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

2768000

Quarters > 1 > balance Sheet > cash

76319000

Quarters > 1 > balance Sheet > short Term Investments

182859000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

268586000

Quarters > 1 > balance Sheet > property Plant Equipment

4546000

Quarters > 1 > balance Sheet > total Assets

281924000

Quarters > 1 > balance Sheet > payables

738000

Quarters > 1 > balance Sheet > short Term Debt

1399000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

21412000

Quarters > 1 > balance Sheet > equity

260512000

Quarters > 1 > cash Flow > net Income

-33052000

Quarters > 1 > cash Flow > depreciation

-1891000

Quarters > 1 > cash Flow > change In Working Capital

-6874000

Quarters > 1 > cash Flow > cash From Operations

-36058000

Quarters > 1 > cash Flow > capital Expenditures

590000

Quarters > 1 > cash Flow > cash From Investing

57992000

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

21934000

Quarters > 1 > ratios > PE

-0.5698098822397507

Quarters > 1 > ratios > PB

2.8878857658764283

Quarters > 1 > ratios > ROE

-12.687323424640706

Quarters > 1 > ratios > ROA

-11.72372696187625

Quarters > 1 > ratios > FCF

-36648000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

36995000

Quarters > 2 > income Statement > operating Income

-36995000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-33709000

Quarters > 2 > income Statement > net Income

-33709000

Quarters > 2 > income Statement > eps

-0.5811364310910008

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

58005312

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-36995000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

3286000

Quarters > 2 > balance Sheet > cash

54385000

Quarters > 2 > balance Sheet > short Term Investments

240679000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

302968000

Quarters > 2 > balance Sheet > property Plant Equipment

4833000

Quarters > 2 > balance Sheet > total Assets

310387000

Quarters > 2 > balance Sheet > payables

3695000

Quarters > 2 > balance Sheet > short Term Debt

1392000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

21097000

Quarters > 2 > balance Sheet > equity

289290000

Quarters > 2 > cash Flow > net Income

-33709000

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

-3396000

Quarters > 2 > cash Flow > cash From Operations

-34018000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

28583000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-5435000

Quarters > 2 > ratios > PE

-0.5811364310910008

Quarters > 2 > ratios > PB

2.600604572021155

Quarters > 2 > ratios > ROE

-11.65232120017975

Quarters > 2 > ratios > ROA

-10.860313093009696

Quarters > 2 > ratios > FCF

-34018000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

29591000

Quarters > 3 > income Statement > operating Income

-29591000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-25626000

Quarters > 3 > income Statement > net Income

-25626000

Quarters > 3 > income Statement > eps

-0.4540861990134036

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

56434219

Quarters > 3 > income Statement > income Tax Expense

43276

Quarters > 3 > income Statement > EBITDA

-29591000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

3965000

Quarters > 3 > balance Sheet > cash

59820000

Quarters > 3 > balance Sheet > short Term Investments

268312000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

334643000

Quarters > 3 > balance Sheet > property Plant Equipment

5114000

Quarters > 3 > balance Sheet > total Assets

342363000

Quarters > 3 > balance Sheet > payables

4320000

Quarters > 3 > balance Sheet > short Term Debt

1384000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

23100000

Quarters > 3 > balance Sheet > equity

319263000

Quarters > 3 > cash Flow > net Income

-25626000

Quarters > 3 > cash Flow > depreciation

-43276

Quarters > 3 > cash Flow > change In Working Capital

5942000

Quarters > 3 > cash Flow > cash From Operations

-17362000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-3717000

Quarters > 3 > cash Flow > cash From Financing

0

Quarters > 3 > cash Flow > net Change In Cash

-21079000

Quarters > 3 > ratios > PE

-0.4540861990134036

Quarters > 3 > ratios > PB

2.2926296515098836

Quarters > 3 > ratios > ROE

-8.026611289125267

Quarters > 3 > ratios > ROA

-7.4850378107447355

Quarters > 3 > ratios > FCF

-17362000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

43

Valuation > metrics > PE

-0.5455190035009208

Valuation > metrics > PB

3.225377151162043

Valuation > final Score

47.74622848837957

Valuation > verdict

7.5% Overvalued

Profitability > metrics > ROE

-13.56595627923328

Profitability > metrics > ROA

-12.480181111119876

Profitability > metrics > Net Margin

-44.82011331444759

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.16554127921184295

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

99.78197560015742

Liquidity > metrics > Quick Ratio

99.78197560015742

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

8

Prev Risks > 1

15

Prev Risks > 2

30

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-12T14:07:24.579Z